Thutkawkorapin Jessada, Lindblom Annika, Tham Emma
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Mol Genet Genomic Med. 2019 May;7(5):e605. doi: 10.1002/mgg3.605. Epub 2019 Feb 27.
Colorectal cancer (CRC) cases with an age of onset <40 years suggests a germline genetic cause. In total, 51 simplex cases were included to test the hypothesis of CRC as a mendelian trait caused by either heterozygous autosomal dominant or bi-allelic autosomal recessive pathogenic variants.
The cohort was whole exome sequenced (WES) at 100× coverage. Both a dominant- and recessive model were used for searching predisposing genetic factors. In addition, we assayed recessive variants of potential moderate risk that were enriched in our young-onset CRC cohort. Variants were filtered using a candidate cancer gene list or by selecting variants more likely to be pathogenic based on variant type (e.g., loss-of-function) or allele frequency.
We identified one pathogenic variant in PTEN in a patient subsequently confirmed to have a hereditary hamartoma tumor syndrome (Cowden syndrome) and one patient with a pathogenic heterozygous variant in PMS2 that was originally not identified by WES due to low quality reads resulting from pseudogenes. In addition, we identified three heterozygous candidate missense variants in known cancer susceptibility genes (BMPR1A, BRIP1, and SRC), three truncating variants in possibly novel cancer genes (CLSPN, SEC24B, SSH2) and four candidate missense variants in ACACA, NR2C2, INPP4A, and DIDO1. We also identify five possible autosomal recessive candidate genes: ATP10B, PKHD1, UGGT2, MYH13, TFF3.
Two clear pathogenic variants were identified in patients that had not been identified clinically. Thus, the chance of detecting a hereditary cancer syndrome in patients with CRC at young age but without family history is 2/51 (4%) and therefore the clinical benefit of genetic testing in this patient group is low. Of note, using stringent filtering, we have identified a total of ten candidate heterozygous variants and five possibly biallelic autosomal recessive candidate genes that warrant further study.
发病年龄小于40岁的结直肠癌(CRC)病例提示存在种系遗传原因。总共纳入了51例单发病例,以检验CRC作为由杂合常染色体显性或双等位基因常染色体隐性致病变异引起的孟德尔性状这一假说。
对该队列进行全外显子组测序(WES),覆盖度为100×。采用显性和隐性模型来搜索易感遗传因素。此外,我们检测了在年轻发病的CRC队列中富集的潜在中度风险的隐性变异。使用候选癌症基因列表或根据变异类型(如功能丧失)或等位基因频率选择更可能致病的变异对变异进行过滤。
我们在一名随后被确诊患有遗传性错构瘤肿瘤综合征(考登综合征)的患者中鉴定出PTEN中的一个致病变异,以及一名PMS2中存在致病杂合变异的患者,该变异最初由于假基因导致的低质量读数而未被WES鉴定出来。此外,我们在已知癌症易感基因(BMPR1A、BRIP1和SRC)中鉴定出三个杂合候选错义变异,在可能的新型癌症基因(CLSPN、SEC24B、SSH2)中鉴定出三个截短变异,在ACACA、NR2C2、INPP4A和DIDO1中鉴定出四个候选错义变异。我们还鉴定出五个可能的常染色体隐性候选基因:ATP10B、PKHD1、UGGT2、MYH13、TFF3。
在临床上未被识别的患者中鉴定出两个明确的致病变异。因此,在年轻但无家族史的CRC患者中检测到遗传性癌症综合征的几率为2/51(4%),因此该患者群体进行基因检测的临床获益较低。值得注意的是,通过严格筛选,我们总共鉴定出十个候选杂合变异和五个可能的双等位基因常染色体隐性候选基因,值得进一步研究。